Cancer

A microscope image of fluorescently-labeled bacteria in green and colorectal cancer cells in red and blue against a black background.
| 3 min read
A hand hovers under a white pump bottle.
| 6 min read
Colorful 3D schematic of DNA strands against a black background.
| 4 min read
A syringe is delivering medication inside the body to target cancer cells.
| 3 min read
A 3D rendering of a cancer cell dividing into two cells, representing cancer growth
| 8 min read
3D rendering of a therapeutic antibody molecule binding to PD-1 protein on a surface of a t cell.
| 3 min read
A 3D rendering of a ribosome translating a nucleotide sequence to a protein sequence.
| 2 min read
An illustration of cell-free DNA strands circulating through the bloodstream with red blood cells
Available on Demand
A close-up of a blue small structure on a Petri dish.
A screenshot of the audio tracks in Adobe Audition involved in bringing DDN Dialogues podcast listeners along to the nuclear reactor site visit.
| 6 min read
Alice Moore, a researcher at Memorial Sloan Kettering Cancer Center, first demonstrated that viruses could kill tumor cells in living animals.
| 1 min read
A photograph of giraffes, elephants, lions, and zebras walking through a plain in Africa.
| 5 min read
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A 3D illustration of two sphericaA 3D illustration of two spherical cells in close contact, with glowing blue nuclei and additional out-of-focus cells in the background.l cells in close contact, with glowing blue nuclei and additional out-of-focus cells in the background.
Imaging-enabled flow cytometry helps distinguish biologically relevant cell-cell interactions from coincident events to support immunotherapy research.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.